Clinical Trials · NCT07057310
Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women
- Phase
- Phase 4
- Recruitment status
- Enrolling By Invitation
- Sponsor
- Mayo Clinic
- Enrollment
- 30
- Start date
- May 2025
- Locations
- 1 site, United States
- Primary endpoint
- Physical Function Measure: Short Physical Performance Battery (SPPB) score.